(AKZA) Akzo Nobel - Overview
Exchange: AS •
Country: Netherlands •
Currency: EUR •
Type: Common Stock •
ISIN: NL0013267909
Stock: Decorative Paints, Performance Coatings
Total Rating 35
Risk 91
Buy Signal -0.07
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.51% |
| Yield on Cost 5y | 4.65% |
| Yield CAGR 5y | 0.25% |
| Payout Consistency | 90.8% |
| Payout Ratio | 2.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 29.2% |
| Relative Tail Risk | -5.92% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.24 |
| Alpha | 1.55 |
| Character TTM | |
|---|---|
| Beta | 0.200 |
| Beta Downside | 0.174 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.78% |
| CAGR/Max DD | -0.07 |
Description: AKZA Akzo Nobel January 02, 2026
Akzo Nobel N.V. (ticker AKZA) is a global paints and coatings producer organized into two core segments: Decorative Paints, which supplies paints, lacquers, varnishes and color-mixing equipment for building, renovation and automotive markets; and Performance Coatings, which provides protective and functional finishes for ships, cars, aircraft, yachts, architectural components, consumer goods, oil-&-gas facilities and powder-coat applications.
In FY 2023 the company generated approximately €12.5 billion of revenue, with an EBIT margin of roughly 13 %, reflecting the relatively high-value nature of its specialty-chemical portfolio. Key economic drivers include construction-sector cyclicality (which directly impacts Decorative Paints demand), raw-material cost volatility (especially solvents and titanium dioxide), and the ongoing shift toward high-performance, low-VOC powder coatings that benefit from stricter environmental regulations. The firm’s exposure to capital-intensive end-markets such as shipbuilding and automotive aligns its performance with global industrial activity trends.
For a deeper, data-driven assessment of AKZA’s valuation and risk profile, you may find ValueRay’s analytical dashboard useful.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 58.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -0.34 > 1.0 |
| NWC/Revenue: 11.57% < 20% (prev 11.26%; Δ 0.31% < -1%) |
| CFO/TA 0.06 > 3% & CFO 851.0m > Net Income 58.0m |
| Net Debt (4.03b) to EBITDA (891.0m): 4.52 < 3 |
| Current Ratio: 1.25 > 1.5 & < 3 |
| Outstanding Shares: last quarter (171.0m) vs 12m ago 0.12% < -2% |
| Gross Margin: 39.78% > 18% (prev 0.41%; Δ 3937 % > 0.5%) |
| Asset Turnover: 71.16% > 50% (prev 69.20%; Δ 1.96% > 0%) |
| Interest Coverage Ratio: 2.89 > 6 (EBITDA TTM 891.0m / Interest Expense TTM 179.0m) |
Altman Z'' 2.42
| A: 0.09 (Total Current Assets 6.04b - Total Current Liabilities 4.84b) / Total Assets 13.90b |
| B: 0.36 (Retained Earnings 5.07b / Total Assets 13.90b) |
| C: 0.04 (EBIT TTM 517.0m / Avg Total Assets 14.62b) |
| D: 0.40 (Book Value of Equity 3.93b / Total Liabilities 9.75b) |
| Altman-Z'' Score: 2.42 = A |
Beneish M -3.09
| DSRI: 0.97 (Receivables 2.84b/3.00b, Revenue 10.40b/10.62b) |
| GMI: 1.03 (GM 39.78% / 40.82%) |
| AQI: 1.02 (AQ_t 0.40 / AQ_t-1 0.39) |
| SGI: 0.98 (Revenue 10.40b / 10.62b) |
| TATA: -0.06 (NI 58.0m - CFO 851.0m) / TA 13.90b) |
| Beneish M-Score: -3.09 (Cap -4..+1) = AA |
What is the price of AKZA shares?
As of February 08, 2026, the stock is trading at EUR 58.64 with a total of 663,039 shares traded.
Over the past week, the price has changed by -1.11%, over one month by -0.88%, over three months by +2.84% and over the past year by +5.67%.
Over the past week, the price has changed by -1.11%, over one month by -0.88%, over three months by +2.84% and over the past year by +5.67%.
Is AKZA a buy, sell or hold?
Akzo Nobel has no consensus analysts rating.
What are the forecasts/targets for the AKZA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 69.1 | 17.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 63.3 | 7.9% |
AKZA Fundamental Data Overview February 03, 2026
Market Cap USD = 11.97b (10.14b EUR * 1.1801 EUR.USD)
P/E Trailing = 179.697
P/E Forward = 13.9276
P/S = 0.9749
P/B = 2.5682
P/EG = 0.881
Revenue TTM = 10.40b EUR
EBIT TTM = 517.0m EUR
EBITDA TTM = 891.0m EUR
Long Term Debt = 3.47b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 1.70b EUR (from shortTermDebt, last quarter)
Debt = 5.35b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.03b EUR (from netDebt column, last quarter)
Enterprise Value = 14.17b EUR (10.14b + Debt 5.35b - CCE 1.32b)
Interest Coverage Ratio = 2.89 (Ebit TTM 517.0m / Interest Expense TTM 179.0m)
EV/FCF = 26.29x (Enterprise Value 14.17b / FCF TTM 539.0m)
FCF Yield = 3.80% (FCF TTM 539.0m / Enterprise Value 14.17b)
FCF Margin = 5.18% (FCF TTM 539.0m / Revenue TTM 10.40b)
Net Margin = 0.56% (Net Income TTM 58.0m / Revenue TTM 10.40b)
Gross Margin = 39.78% ((Revenue TTM 10.40b - Cost of Revenue TTM 6.27b) / Revenue TTM)
Gross Margin QoQ = 40.32% (prev 39.53%)
Tobins Q-Ratio = 1.02 (Enterprise Value 14.17b / Total Assets 13.90b)
Interest Expense / Debt = 0.84% (Interest Expense 45.0m / Debt 5.35b)
Taxrate = 29.36% (246.0m / 838.0m)
NOPAT = 365.2m (EBIT 517.0m * (1 - 29.36%))
Current Ratio = 1.25 (Total Current Assets 6.04b / Total Current Liabilities 4.84b)
Debt / Equity = 1.36 (Debt 5.35b / totalStockholderEquity, last quarter 3.93b)
Debt / EBITDA = 4.52 (Net Debt 4.03b / EBITDA 891.0m)
Debt / FCF = 7.48 (Net Debt 4.03b / FCF TTM 539.0m)
Total Stockholder Equity = 4.33b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.40% (Net Income 58.0m / Total Assets 13.90b)
RoE = 1.34% (Net Income TTM 58.0m / Total Stockholder Equity 4.33b)
RoCE = 6.63% (EBIT 517.0m / Capital Employed (Equity 4.33b + L.T.Debt 3.47b))
RoIC = 5.94% (NOPAT 365.2m / Invested Capital 6.15b)
WACC = 4.56% (E(10.14b)/V(15.50b) * Re(6.65%) + D(5.35b)/V(15.50b) * Rd(0.84%) * (1-Tc(0.29)))
Discount Rate = 6.65% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.12%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈582.6m ; Y1≈382.4m ; Y5≈174.5m
Fair Price DCF = 8.94 (EV 5.56b - Net Debt 4.03b = Equity 1.53b / Shares 171.1m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -29.11 | EPS CAGR: -56.66% | SUE: -4.0 | # QB: 0
Revenue Correlation: -2.43 | Revenue CAGR: 1.56% | SUE: 0.58 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.93 | Chg30d=-0.079 | Revisions Net=-2 | Analysts=3
EPS next Year (2026-12-31): EPS=3.97 | Chg30d=-0.139 | Revisions Net=-6 | Growth EPS=+45.8% | Growth Revenue=-1.3%
P/E Trailing = 179.697
P/E Forward = 13.9276
P/S = 0.9749
P/B = 2.5682
P/EG = 0.881
Revenue TTM = 10.40b EUR
EBIT TTM = 517.0m EUR
EBITDA TTM = 891.0m EUR
Long Term Debt = 3.47b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 1.70b EUR (from shortTermDebt, last quarter)
Debt = 5.35b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.03b EUR (from netDebt column, last quarter)
Enterprise Value = 14.17b EUR (10.14b + Debt 5.35b - CCE 1.32b)
Interest Coverage Ratio = 2.89 (Ebit TTM 517.0m / Interest Expense TTM 179.0m)
EV/FCF = 26.29x (Enterprise Value 14.17b / FCF TTM 539.0m)
FCF Yield = 3.80% (FCF TTM 539.0m / Enterprise Value 14.17b)
FCF Margin = 5.18% (FCF TTM 539.0m / Revenue TTM 10.40b)
Net Margin = 0.56% (Net Income TTM 58.0m / Revenue TTM 10.40b)
Gross Margin = 39.78% ((Revenue TTM 10.40b - Cost of Revenue TTM 6.27b) / Revenue TTM)
Gross Margin QoQ = 40.32% (prev 39.53%)
Tobins Q-Ratio = 1.02 (Enterprise Value 14.17b / Total Assets 13.90b)
Interest Expense / Debt = 0.84% (Interest Expense 45.0m / Debt 5.35b)
Taxrate = 29.36% (246.0m / 838.0m)
NOPAT = 365.2m (EBIT 517.0m * (1 - 29.36%))
Current Ratio = 1.25 (Total Current Assets 6.04b / Total Current Liabilities 4.84b)
Debt / Equity = 1.36 (Debt 5.35b / totalStockholderEquity, last quarter 3.93b)
Debt / EBITDA = 4.52 (Net Debt 4.03b / EBITDA 891.0m)
Debt / FCF = 7.48 (Net Debt 4.03b / FCF TTM 539.0m)
Total Stockholder Equity = 4.33b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.40% (Net Income 58.0m / Total Assets 13.90b)
RoE = 1.34% (Net Income TTM 58.0m / Total Stockholder Equity 4.33b)
RoCE = 6.63% (EBIT 517.0m / Capital Employed (Equity 4.33b + L.T.Debt 3.47b))
RoIC = 5.94% (NOPAT 365.2m / Invested Capital 6.15b)
WACC = 4.56% (E(10.14b)/V(15.50b) * Re(6.65%) + D(5.35b)/V(15.50b) * Rd(0.84%) * (1-Tc(0.29)))
Discount Rate = 6.65% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.12%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈582.6m ; Y1≈382.4m ; Y5≈174.5m
Fair Price DCF = 8.94 (EV 5.56b - Net Debt 4.03b = Equity 1.53b / Shares 171.1m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -29.11 | EPS CAGR: -56.66% | SUE: -4.0 | # QB: 0
Revenue Correlation: -2.43 | Revenue CAGR: 1.56% | SUE: 0.58 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.93 | Chg30d=-0.079 | Revisions Net=-2 | Analysts=3
EPS next Year (2026-12-31): EPS=3.97 | Chg30d=-0.139 | Revisions Net=-6 | Growth EPS=+45.8% | Growth Revenue=-1.3%